olivLaw · US equity research
Universal Corporation UVV
Wholesale-Farm Product Raw Materials · SIC 5150 · Vertical: Wholesale — nondurable goods (SIC 51xx)
Universal Corporation is a global business-to-business agriproducts company, a leading global supplier of leaf tobacco and a processor of plant-based ingredients. The company generated about 2.9 billion dollars of revenue in fiscal 2026, while in the first quarter of fiscal 2027 tobacco oversupply and high fixed costs in ingredients weighed heavily on results.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Universal Corporation (UVV) stock was 39.75 USD (+0.71% on the day), with market capitalisation 990.8 m USD, dividend yield 8.30%, beta 0.06, 52-week range 38.22–58.77 USD. Latest reported quarter (Q2 2027): revenue of 617.4 m USD (−17.6% YoY), net income of 12.6 m USD (−63.2% YoY), diluted EPS 0.50 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 42.0
- weak (30–45)
- Bollinger (20, 2)
- 37.99 – 42.73
- in the lower half of the band · %B 0.37 · band width 11.7%
- SMA 50 / 200
- 42.62 / 50.13
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.76 / -0.95
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −5.6% | −1.1% | −4.6 pp | — |
| 3 months | −23.7% | −0.5% | −23.2 pp | — |
| 6 months | −26.3% | +4.4% | −30.6 pp | — |
| Year to date | −24.6% | +12.3% | −37.0 pp | — |
| 1 year | −22.7% | +13.5% | −36.2 pp | −0.6% |
| 3 years | −21.5% | +76.4% | −97.9 pp | +2.3% |
| 5 years | −21.2% | +63.7% | −84.9 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2027 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | Q2 '27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 928.0 m | 690.2 m | 592.6 m | 749.4 m | 853.2 m | 689.9 m | 520.3 m | 617.4 m |
| Cost of revenue | 743.6 m | 586.3 m | 479.6 m | 614.3 m | 701.7 m | 616.8 m | 440.7 m | 514.3 m |
| SG&A | 89.5 m | 73.2 m | 79.2 m | 72.2 m | 76.9 m | 72.4 m | 80.8 m | 67.6 m |
| Operating income | 104.1 m | 42.8 m | 33.8 m | 67.6 m | 82.0 m | -15.0 m | 2.3 m | 42.6 m |
| Depreciation & amortisation | 15.1 m ≈ | 15.2 m | 13.6 m | 13.6 m ≈ | 13.0 m ≈ | 13.2 m | 12.8 m | 13.0 m ≈ |
| Interest expense | 19.3 m | 18.3 m | 17.8 m | 20.4 m | 17.3 m | 18.6 m | 16.5 m | 18.4 m |
| Income tax | 20.2 m | 6.4 m | 5.3 m | 11.2 m | 25.3 m | 4.8 m | -4.5 m | 9.2 m |
| Net income | 59.6 m | 9.3 m | 8.5 m | 34.2 m | 33.2 m | -43.3 m | -5.0 m | 12.6 m |
| Diluted EPS | 2.37 | 0.37 ≈ | 0.34 | 1.36 | 1.32 | -1.72 ≈ | -0.20 | 0.50 |
| Operating cash flow | 215.6 m ≈ | 158.7 m | -205.1 m | 32.7 m ≈ | 114.3 m ≈ | 187.1 m | -117.1 m | -96.7 m ≈ |
| Capex | 16.1 m ≈ | 7.7 m | 12.1 m | 9.0 m ≈ | 19.2 m ≈ | 8.5 m | 15.9 m | 19.6 m ≈ |
| Dividends paid | 20.0 m ≈ | 20.0 m | 20.0 m | 20.4 m ≈ | 20.4 m ≈ | 20.4 m | 20.4 m | 20.7 m ≈ |
| Share repurchases | 0 ≈ | 0 | 0 | 0 ≈ | — | — | 2.7 m | 2.3 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2 bn | 1.9 bn | 2.0 bn | 2.1 bn | 2.5 bn | 2.7 bn | 2.9 bn | 2.9 bn |
| Revenue YoY | +9.6% | −14.5% | +3.9% | +6.4% | +21.9% | +6.7% | +7.4% | −1.3% |
| Net income | 104.1 m | 71.7 m | 87.4 m | 86.6 m | 124.1 m | 119.6 m | 95.0 m | 32.6 m |
| Net income YoY | −1.5% | −31.2% | +21.9% | −1.0% | +43.3% | −3.6% | −20.5% | −65.7% |
| Diluted EPS | 4.11 | 2.86 | 3.53 | 3.47 | 4.97 | 4.78 | 3.78 | 1.30 |
| Diluted EPS YoY | −0.7% | −30.4% | +23.4% | −1.7% | +43.2% | −3.8% | −20.9% | −65.6% |
| net % | 4.7% | 3.8% | 4.4% | 4.1% | 4.9% | 4.4% | 3.3% | 1.1% |
| Free cash flow | 125.8 m | -24.3 m | 154.3 m | -8.3 m | -65.2 m | -140.6 m | 264.4 m | 80.3 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 31 Mar 2026
- Cash
- 62.2 m USD
- Financial debt
- 904.3 m USD
- Net debt
- 842.1 m USD
- Equity
- 1.5 bn USD
- Total assets
- 2.8 bn USD
- Debt / equity
- 0.62x
- Current ratio
- 3.49x
- ROE
- 2.2%
- ROA
- 1.1%
- FCF margin
- 2.8%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 2.0 bn | 2.1 bn | 2.5 bn | 2.7 bn | 2.9 bn | 2.9 bn | SEC (XBRL)· 01 Jun 2026verified |
| Cost of revenue | 1.6 bn | 1.7 bn | 2.1 bn | 2.2 bn | 2.4 bn | 2.4 bn | SEC (XBRL)· 01 Jun 2026verified |
| Gross profit | 368.1 m ≈ | 396.5 m ≈ | 438.3 m ≈ | 509.2 m ≈ | 524.3 m ≈ | 472.6 m ≈ | SEC (XBRL)· 01 Jun 2026derived |
| SG&A | 219.8 m | 240.7 m | 277.2 m | 310.6 m | 305.3 m | 300.7 m | SEC (XBRL)· 01 Jun 2026verified |
| Operating income | 147.8 m | 160.3 m | 181.1 m | 222.0 m | 232.8 m | 168.5 m | SEC (XBRL)· 01 Jun 2026verified |
| Depreciation & amortisation | 44.7 m | 52.5 m | 57.3 m | 58.3 m | 59.8 m | 53.4 m | SEC (XBRL)· 01 Jun 2026verified |
| EBITDA | 192.5 m ≈ | 212.8 m ≈ | 238.4 m ≈ | 280.3 m ≈ | 292.6 m ≈ | 221.9 m ≈ | SEC (XBRL)· 01 Jun 2026derived |
| Interest expense | 25.0 m | 27.7 m | 49.3 m | 66.3 m | 79.6 m | 74.0 m | SEC (XBRL)· 01 Jun 2026verified |
| Pre-tax income | 125.7 m | 142.3 m | 142.0 m | 164.1 m | 154.2 m | 102.7 m | SEC (XBRL)· 01 Jun 2026verified |
| Income tax | 29.4 m | 38.7 m | 11.7 m | 31.1 m | 40.9 m | 46.7 m | SEC (XBRL)· 01 Jun 2026verified |
| Net income | 87.4 m | 86.6 m | 124.1 m | 119.6 m | 95.0 m | 32.6 m | SEC (XBRL)· 01 Jun 2026verified |
| Diluted EPS | 3.53 | 3.47 | 4.97 | 4.78 | 3.78 | 1.30 | SEC (XBRL)· 01 Jun 2026verified |
| Weighted average diluted shares | 24.8 m | 24.9 m | 24.9 m | 25.0 m | 25.1 m | 25.2 m | SEC (XBRL)· 01 Jun 2026verified |
| Dividend per share | 3.08 | 3.12 | 3.16 | 3.20 | 3.24 | 3.28 | SEC (XBRL)· 01 Jun 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue; Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 197.2 m | 81.6 m | 64.7 m | 55.6 m | 260.1 m | 62.2 m | SEC (XBRL)· 01 Jun 2026verified |
| Receivables | 367.5 m | 385.4 m | 402.1 m | 525.3 m | 625.9 m | 563.9 m | SEC (XBRL)· 01 Jun 2026verified |
| Current assets | 1.6 bn | 1.7 bn | 1.8 bn | 2.1 bn | 2.2 bn | 2.0 bn | SEC (XBRL)· 01 Jun 2026verified |
| Property, plant & equipment, net | 349.5 m | 345.1 m | 351.2 m | 365.9 m | 373.0 m | 373.0 m | SEC (XBRL)· 01 Jun 2026verified |
| Goodwill | 173.1 m | 214.0 m | 213.9 m | 213.9 m | 213.8 m | 172.7 m | SEC (XBRL)· 01 Jun 2026verified |
| Intangibles (excl. goodwill) | 72.3 m | 92.6 m | 80.1 m | 68.9 m | 57.8 m | 48.6 m | SEC (XBRL)· 01 Jun 2026verified |
| Total assets | 2.3 bn | 2.6 bn | 2.6 bn | 2.9 bn | 3.0 bn | 2.8 bn | SEC (XBRL)· 01 Jun 2026verified |
| Accounts payable | 139.5 m | 272.0 m | — | — | — | — | SEC (XBRL)· 27 May 2022verified |
| Short-term debt | 101.3 m | 182.6 m | 195.6 m | 417.2 m | 455.0 m | 287.6 m | SEC (XBRL)· 01 Jun 2026verified |
| Long-term debt | 518.2 m | 518.5 m | 616.8 m | 617.4 m | 617.9 m | 616.7 m | SEC (XBRL)· 01 Jun 2026verified |
| Current liabilities | 293.2 m | 518.7 m | 442.0 m | 711.4 m | 750.2 m | 564.2 m | SEC (XBRL)· 01 Jun 2026verified |
| Total liabilities | 993.5 m | 1.2 bn | 1.2 bn | 1.5 bn | 1.5 bn | 1.3 bn | SEC (XBRL)· 01 Jun 2026verified |
| Equity | 1.3 bn | 1.4 bn | 1.4 bn | 1.5 bn | 1.5 bn | 1.5 bn | SEC (XBRL)· 01 Jun 2026verified |
| Shares outstanding at year end | — | — | — | — | 24.7 m | — | SEC (XBRL)· 07 Aug 2024verified |
Cash flow · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 220.4 m | 44.9 m | -10.6 m | -74.6 m | 327.0 m | 129.1 m | SEC (XBRL)· 01 Jun 2026verified |
| Capex | 66.2 m | 53.2 m | 54.7 m | 66.0 m | 62.6 m | 48.8 m | SEC (XBRL)· 01 Jun 2026verified |
| Free cash flow | 154.3 m ≈ | -8.3 m ≈ | -65.2 m ≈ | -140.6 m ≈ | 264.4 m ≈ | 80.3 m ≈ | SEC (XBRL)· 01 Jun 2026derived |
| Investing cash flow | -217.3 m | -142.7 m | -50.4 m | -60.0 m | -58.8 m | -43.0 m | SEC (XBRL)· 01 Jun 2026verified |
| Financing cash flow | 91.4 m | -16.8 m | 38.9 m | 125.7 m | -63.2 m | -284.3 m | SEC (XBRL)· 01 Jun 2026verified |
| Dividends paid | 75.2 m | 76.4 m | 77.4 m | 78.4 m | 79.7 m | 81.3 m | SEC (XBRL)· 01 Jun 2026verified |
| Share repurchases | 0 | 3.1 m | 3.4 m | 4.7 m | 0 | 0 | SEC (XBRL)· 01 Jun 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 35 / 100
A scoring methodology on indicators and valuation, not investment advice.
score < 40
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 990.8 m USD
Key indicators
Coverage and freshness
Score by group
- Valuation40
- Balance sheet20
- Quality49
- Growth18
- Returns60
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 6.27 – 79.40 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)11.39 – 79.40 (Mid 32.29)WACC 6.4% · starting FCFF 71.1 m USD · terminal value share of EV 83%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 8.2%
- Peers: EV/EBITDA6.27 – 63.66 (Mid 33.31)16 companies used · median multiple 12.1x · quartiles 8.0x – 16.7xASH, CAH, CAPL, CHEF, COR, DIT, DPZ, HWKN, MCK, MMLP, NUS, SEB, SYY, UNFI, USFD, VSTS
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)43.10 – 57.97 (Mid 49.44)
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Unattractive profile · Score 35/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 2.9% | 50 (vs peers) | 13% |
| Net margin · Quality | -0.1% | 46 (vs peers) | 8% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 4.2% | 35 (on a fixed band) | 10% |
| EPS CAGR 3Y · Growth | -36.0% | 0 (on a fixed band) | 10% |
| Net debt / EBITDA · Balance sheet | 7.0x | 0 (vs peers) | 13% |
| Interest coverage · Balance sheet | 1.6x | 1 (on a fixed band) | 8% |
| Current ratio · Balance sheet | 2.5x | 100 (on a fixed band) | 5% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | 13.1x | 47 (vs peers) | 13% |
| FCF yield · Valuation | 2.5% | 31 (on a fixed band) | 10% |
| Shareholder yield (distributions) · Returns | 8.8% | 100 (on a fixed band) | 8% |
| Payout ratio (FCF) · Returns | 336.3% | 0 (on a fixed band) | 5% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet20/100 · 3/3 factors with a value
- Growth18/100 · 2/2 factors with a value
- Quality49/100 · 2/3 factors with a value
- Returns60/100 · 2/2 factors with a value
- Valuation40/100 · 2/3 factors with a value
Memo
UNIVERSAL CORPORATION (UVV). Latest full fiscal year: 2026; data up to 2026-09-30.
Figures computed from the financial statements: revenue 2.9 bn USD in 2026; YoY growth -1.3%; net margin -0.1%; ROE -0.2%; net debt/EBITDA 7.0x.
The estimated value range is 11.39–63.66 USD per share (median of 3 methods, agreement: medium); assumptions are illustrative. Against the central value of 33.31 USD, the price of 39.75 USD leaves a potential of -16.2% (value / price − 1) and a margin of safety of -19.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 35/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 2.5x
- Shareholder yield (distributions): 8.8%
What contradicts it
- EPS CAGR 3Y: -36.0%
- Net debt / EBITDA: 7.0x
- Interest coverage: 1.6x
- Payout ratio (FCF): 336.3%
Not assessed (insufficient data or a ratio without meaning): FCF conversion, P/E (TTM).
Versus the vertical median
Wholesale — nondurable goods (SIC 51xx) · same major group (2-digit SIC) · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MCKMcKESSON CORPORATION | 123.5 bn | 27.5 | — | 1.1% | +12.4% | +21% / +127% |
| CORCencora, Inc. | 67.6 bn | 26.3 | 104.3% | 0.8% | +9.3% | −4% / +74% |
| CAHCardinal Health, Inc. | 60.9 bn | 36.2 | — | 0.7% | +14.2% | +23% / +145% |
| SYYSysco Corporation | 37.9 bn | 20.5 | 59.1% | 2.1% | +3.9% | +1% / +7% |
| USFDUs Foods Holding Corp. | 23.8 bn | 33.8 | 16.4% | 1.8% | +4.1% | +40% / +151% |
| PFGCPerformance Food Group Company | 17.3 bn | 43.7 | 8.2% | 0.6% | +7.2% | +13% / +68% |
| DPZDomino’s Pizza, Inc. | 11.2 bn | 19.3 | — | 11.9% | +5.0% | −19% / −13% |
| CHEFChefs’ Warehouse, Inc. | 4.6 bn | 46.5 | 16.2% | 2.3% | +9.4% | +74% / +297% |
| ASHAshland Inc. | 3.5 bn | 126.3 | 2.8% | 2.8% | −13.7% | +44% / −4% |
| SEBSeaboard Corporation | 3.3 bn | 5.9 | 10.7% | 5.3% | +7.1% | −26% / −2% |
| HWKNHawkins, Inc. | 3.2 bn | 37.9 | 16.0% | 7.5% | +11.2% | +20% / +154% |
| UNFIUnited Natural Foods, Inc. | 2.9 bn | 36.0 | 5.3% | 0.3% | −2.0% | +29% / +232% |
| VSTSVestis Corp | 2.0 bn | — | -0.6% | -0.2% | −2.5% | +128% / −19% |
| WKCWorld Kinect Corporation | 1.9 bn | — | -11.5% | -0.4% | −12.5% | +64% / +81% |
| ANDEAndersons, Inc. | 1.9 bn | 9.3 | 16.1% | 1.8% | −2.2% | +7% / +11% |
| GLPGlobal Partners LP | 1.5 bn | 7.6 | — | 0.9% | +8.1% | −1% / +19% |
| UVVUniversal Corporation | 990.8 m | — | -0.2% | -0.1% | −1.3% | −23% / −21% |
| CAPLCrossamerica Partners LP | 773.8 m | 16.1 | — | 1.2% | −10.6% | −1% / −15% |
| WEYSWeyco Group, Inc. | 616.9 m | 17.8 | 13.8% | 12.4% | −4.9% | +116% / +119% |
| MGPIMgp Ingredients, Inc. | 364.2 m | — | -34.5% | -51.4% | −23.8% | −25% / −80% |
| NUSNu Skin Enterprises, Inc. | 242.9 m | — | -32.5% | -15.7% | −14.3% | −50% / −71% |
| HFFGHf Foods Group Inc. | 80.3 m | — | -15.5% | -2.8% | +2.2% | −41% / −69% |
| BANLCbl International Limited | 80.0 m | — | -14.0% | -0.6% | −9.1% | −48% / −86% |
| MMLPMartin Midstream Partners L.P. | 77.1 m | — | — | -1.4% | +1.2% | −25% / −24% |
| DITAmcon Distributing Co | 59.4 m | 33.1 | 1.6% | 0.1% | +3.9% | −19% / −48% |
1- and 3-year price returns: for UVV from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 05 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).
In brief
Universal Corporation is a global business-to-business agriproducts company, a leading global supplier of leaf tobacco and a processor of plant-based ingredients. The company generated about 2.9 billion dollars of revenue in fiscal 2026, while in the first quarter of fiscal 2027 tobacco oversupply and high fixed costs in ingredients weighed heavily on results.
SWOT
Strengths
- The company's position as the leading global leaf tobacco supplier, with presence in all major origins and long customer relationships, supports volumes and access to supply 1.
- A global processing and storage network and supply chain expertise allow customized services that large customers increasingly require 1.
- Liquidity described as strong, with debt down from the prior year, gives flexibility through seasonal purchasing cycles 23.
Weaknesses
- Reliance on a few large customers makes revenue sensitive to the loss of a client or a rise in their vertical integration 1.
- The ingredients division carries high fixed costs after the Lancaster expansion, and its operating result has been close to breakeven or negative in recent reports 13.
- Repeated inventory write-downs and goodwill impairment show exposure to tobacco oversupply and long sales cycles 12.
Opportunities
- Organic growth and disciplined acquisitions in ingredients could capture demand for premium and functional products if commercial execution improves 1.
- Development of liquid nicotine and services for next generation product makers could open new revenue streams 1.
- Use of artificial intelligence and digital farm data platforms could improve operating efficiency and supply chain transparency 1.
Threats
- Declining cigarette consumption and the growth of alternative nicotine products could reduce demand for the company's tobacco 1.
- Tariffs, cost volatility and regional conflicts could reduce margins if costs cannot be passed on to customers 12.
- Weather and climate risks could affect crop size and quality and access to raw materials 1.
Risks
- Dependence on a few large customershigh
Loss of a major customer or a significant drop in demand could seriously hurt sales, and consolidation among customers could amplify this effect 1.
- Tobacco oversupplyhigh
A prolonged imbalance between supply and demand could lead to inventory write-downs and lower margins, as occurred in fiscal 2026 12.
- Fixed costs in ingredientsmedium
If the Lancaster facility does not improve its utilization, fixed costs could keep the segment at an operating loss 23.
- Tariffs and cost inflationmedium
Trade uncertainty and rising energy and fertilizer costs could limit the company's ability to pass costs on to customers 1.
- Climate and regulatory riskslow
Climate change and regulation of emissions could raise costs or reduce crop availability 1.
Investment thesis
What would need to be true (bull case)
- The leading global position in tobacco, combined with presence in all major origins, could support long-term profitability, particularly if oversupply eases 12.
- If the ingredients division improves utilization of its plants, the recent investments could turn fixed costs into a scale advantage 13.
- Liquidity described as solid and lower debt could provide flexibility for future acquisitions or strategic investments 23.
What would break the thesis
- Dependence on a few large customers and their possible consolidation could significantly reduce sales in a negative cycle 1.
- Weak quarterly results in tobacco and the ingredients loss suggest margins could stay under pressure for longer 23.
- Falling tobacco consumption and growth of alternative products could structurally affect long-term demand 1.
What to watch
- Level of uncommitted tobacco inventory and sales pace in the second half of the fiscal yearQ2 2027
- Results of the Ingredients division and improvement in Lancaster facility utilization2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 05 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).
The business
Universal Corporation operates through two segments: Tobacco Operations, which procures, processes and ships leaf tobacco to consumer tobacco manufacturers, and Ingredients Operations, which through the Universal Ingredients platform produces juices, concentrates, dehydrated products, botanical extracts and flavorings for the food and beverage industry. The company does not sell directly to consumers but supports manufacturers with transformed agriproducts and related services. Revenue for fiscal 2026 was approximately 2.9 billion dollars 1.
The company contracts directly with farmers and farmer organizations in most countries where it operates, offering crop input packages and agronomic support including good agricultural practices training. Its model depends on seasonal tobacco processing, typically run for seven to nine months a year, with shipments weighted toward the second half of the fiscal year 1.
The ingredients business was built through strategic acquisitions including FruitSmart, Silva and Shank's, and recent investments at the Lancaster facility expanded beverage and food service production capacity. These investments also brought high fixed costs that pressured segment margins in fiscal 2026 and the first quarter of fiscal 2027 12.
Market context
In plant-based ingredients the market is large and highly fragmented, with participants ranging from small private firms to multinational suppliers. The company argues that combining global sourcing with value-added processing and customer-focused innovation differentiates it, although competition and price pressure limit margins 1.
Trends
- Tobacco oversupplyheadwind
Oversupply, particularly for flue-cured and burley tobacco, has pressed on purchasing and sales, and the company has noted that disciplined buying could help it navigate conditions in the near term 23.
- Declining cigarette consumption and alternativesheadwind
Customer demand for tobacco depends on trends in cigarette consumption, alternative nicotine products and illicit trade, factors that could reduce volumes if these trends intensify 1.
- Demand for natural and functional ingredientstailwind
Growing demand for premium, functional and clean-label ingredients supports the growth strategy of the ingredients division, though this depends on commercial execution and use of capacity 1.
- Tariffs and cost pressuresmixed
Tariffs and volatility in energy, fertilizer and freight costs could reduce margins if they cannot be passed on to customers, and regional conflicts have added to these pressures 12.
Competitive position
In global leaf tobacco the principal competitor is Pyxus International, Inc., and the two companies are the only global leaf suppliers with comparable worldwide scope. Smaller competitors operate with lower cost structures and offer lower prices but give farmers less agronomic support 1.
In ingredients, competition comes from many suppliers focused on specific categories or regions, and customers may source directly from growers. The company argues that integrating global sourcing with value-added processing gives it a differentiating advantage 1.
- Pyxus International, Inc.
The company's principal competitor in leaf tobacco, described as the only other global leaf supplier with comparable worldwide scope 1.
- Smaller leaf tobacco suppliers
Local and regional operators competing on purchases and sales with lower overhead and lower prices but limited support for farmers 1.
- Vertically integrated customers
Tobacco product manufacturers that source leaf directly from farmers and compete with the company for leaf in several major markets 1.
- Fragmented plant-based ingredient suppliers
Small private companies and multinational suppliers focused on specific categories or regions that compete in the ingredients segment 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Universal In-Plane Confined Growth of Mesoporous Metal–Organic Framework Crystalline HeterostructuresACS Nano · 04 Nov 2026 · EN
- A tiny Pacific country rolls out universal basic incomeHacker News · 01 Nov 2026 · EN
- Supreme Court hears religious freedom case centered on universal pre-K programNPR News · 01 Nov 2026 · EN
- Fine-Tuning Universal Machine Learning Potentials Enables Efficient Computation of Li Electrode Potentials in Battery ElectrolytesJournal of the American Chemical Society · 31 Oct 2026 · EN
- Lithuania plans universal military conscription from 2032Anadolu Agency (TR, EN) · 30 Oct 2026 · EN
- Universal Music Subscription Revenue Growth Shows ImprovementBloomberg Markets · 29 Oct 2026 · EN
- Lithuania plans to introduce universal military conscription for men ages 18–22 starting in 2032Meduza English (independent RU/exile) · 29 Oct 2026 · EN
- Lithuania has decided. Universal conscription will returnDefence24 (PL, EN) · 29 Oct 2026 · EN
- World has no other universal instrument like UN Security Council — PutinTASS (RU, EN) · 29 Oct 2026 · EN
- Operando Surface Dynamics Govern the pH-Universal Activity and Stability of Cobalt Phosphide for Hydrogen EvolutionJournal of the American Chemical Society · 29 Oct 2026 · EN
- Universal immunization of newborns against RSV could significantly reduce infant hospitalizations in EUMedical Xpress · 28 Oct 2026 · EN
- Universal Music обсуждала переход в частную собственность с инвестфондамиInterfax Russia (RU) · 27 Oct 2026 · RU
- Universal Music Group Discussed Going Private With Buyout FirmsBloomberg Markets · 26 Oct 2026 · EN
- Timiș: Lansarea Catalogului expoziției 'Luminile lui Caravaggio', un omagiu al MNArT adus maestrului șevaletului universalAgerpres · 26 Oct 2026 · RO
- DWP change to Jobcentres for Universal Credit claimants now under waySurge — GDELT DOC · 26 Oct 2026 · RO
- Correction to “Universal and One-Step Modification to Render Diverse Materials Bioactivation”Journal of the American Chemical Society · 23 Oct 2026 · EN
- Efficient equivariant framework for universal charge density predictionNature Machine Intelligence · 23 Oct 2026 · EN
- DWP confirms reassessments for Universal Credit and ESA claimants with some prioritisedSurge — GDELT DOC · 22 Oct 2026 · RO
- Toward a Universal Switch for Microbial Granulation: Photogranule Insights to Advance Granular Wastewater TreatmentEnvironmental Science & Technology · 20 Oct 2026 · EN
- SoftBank weighs $18 billion acquisition of Allied Universal, source saysCNA (Channel NewsAsia) · 16 Oct 2026 · EN
SEC filings
- Current report04 Nov 2026Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report04 Nov 2026
- Current report04 Nov 2026Results of operations · Financial statements and exhibits
- Current report13 Oct 2026Material agreement · Financial statements and exhibits
- Current report18 Sept 2026Departure or appointment of officers
- Quarterly report05 Aug 2026
- Current report05 Aug 2026Results of operations · Shareholder vote · Financial statements and exhibits
- Current report04 Aug 2026Departure or appointment of officers
- Proxy statement01 Jul 2026
- Annual report01 Jun 2026
Sources
- [1] Form 10-K, fiscal year ended 2026-03-31 · SEC / Universal Corporation · 01 Jun 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Universal Corporation · 05 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Universal Corporation · 05 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.